medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2022, Número 1

<< Anterior Siguiente >>

Medicina & Laboratorio 2022; 26 (1)


Fisiología de la tiroides e hipotiroidismo en el embarazo. Revisión de tema

Rueda-Galvis MV, Builes-Barrera CA

Idioma: Español
Referencias bibliográficas: 83
Paginas: 15-33
Archivo PDF: 198.41 Kb.


RESUMEN

Durante el embarazo se generan múltiples cambios fisiológicos a nivel hormonal para llevar a cabo de manera satisfactoria la gestación. Uno de los ejes hormonales con cambios más importantes que repercuten de manera directa en el desarrollo fetal y bienestar materno es el tiroideo, el cual presenta modificaciones para lograr suplir las necesidades de hormona tiroidea tanto materna como fetal, principalmente en las primeras etapas del embarazo. Entre estas, se describen cambios en la cantidad de proteínas transportadoras de hormonas, aumento en el estímulo y producción de hormonas tiroideas, incremento del aclaramiento renal de yodo y alteración en la actividad de las desyodinasas. Estos mecanismos ofrecen suficiente hormona tiroidea al feto, el cual es dependiente del aporte materno. Un desajuste en cualquiera de estos mecanismos, puede conducir al desarrollo de hipotiroidismo con múltiples complicaciones, como la pérdida del embarazo e hipertensión gestacional, entre otras. Una tamización oportuna y un tratamiento temprano pueden evitar estos desenlaces adversos. De ahí la necesidad fundamental de conocer y comprender el comportamiento del eje tiroideo en la gestación.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Moleti M, Trimarchi F, Vermiglio F. Thyroid physiologyin pregnancy. Endocr Pract 2014;20:589-596. https://doi.org/10.4158/ep13341.Ra.

  2. Alexander EK, Pearce EN, Brent GA, BrownRS, Chen H, Dosiou C, et al. 2017 Guidelinesof the American Thyroid Association forthe diagnosis and management of thyroiddisease during pregnancy and the postpartum.Thyroid 2017;27:315-389. https://doi.org/10.1089/thy.2016.0457.

  3. Morais N, Assis ASA, Corcino CM, SaraivaDA, Berbara T, Ventura CDD, et al. Recentrecommendations from ATA guidelines to definethe upper reference range for serum TSHin the first trimester match reference ranges forpregnant women in Rio de Janeiro. Arch EndocrinolMetab 2018;62:386-391. https://doi.org/10.20945/2359-3997000000064.

  4. De Groot L, Abalovich M, Alexander EK,Amino N, Barbour L, Cobin RH, et al. Managementof thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinicalpractice guideline. J Clin Endocrinol Metab2012;97:2543-2565. https://doi.org/10.1210/jc.2011-2803.

  5. Ge GM, Leung MTY, Man KKC, Leung WC, IpP, Li GHY, et al. Maternal thyroid dysfunction duringpregnancy and the risk of adverse outcomesin the offspring: A systematic review and metaanalysis.J Clin Endocrinol Metab 2020;105.https://doi.org/10.1210/clinem/dgaa555.

  6. Springer D, Jiskra J, Limanova Z, Zima T,Potlukova E. Thyroid in pregnancy: Fromphysiology to screening. Crit Rev Clin Lab Sci2017;54:102-116. https://doi.org/10.1080/10408363.2016.1269309.

  7. Yazbeck CF, Sullivan SD. Thyroid disordersduring pregnancy. Med Clin North Am2012;96:235-256. https://doi.org/10.1016/j.mcna.2012.01.004.

  8. Jarvis S, Nelson-Piercy C. Thyroid diseasein pregnancy. In: Gonik B, Weiner C, James D,Steer P, Robson S, eds. High-risk pregnancy:Management options. Cambridge: CambridgeUniversity Press; 2017. p. 1191-1216.

  9. Hume R, Simpson J, Delahunty C, van Toor H,Wu SY, Williams FL, et al. Human fetal and cordserum thyroid hormones: developmental trendsand interrelationships. J Clin Endocrinol Metab2004;89:4097-4103. https://doi.org/10.1210/jc.2004-0573.

  10. Glinoer D, de Nayer P, Bourdoux P, LemoneM, Robyn C, van Steirteghem A, et al. Regulationof maternal thyroid during pregnancy. J ClinEndocrinol Metab 1990;71:276-287. https://doi.org/10.1210/jcem-71-2-276.

  11. Hershman JM. Physiological and pathologicalaspects of the effect of human chorionic gonadotropinon the thyroid. Best Pract Res Clin EndocrinolMetab 2004;18:249-265. https://doi.org/10.1016/j.beem.2004.03.010.

  12. Ballabio M, Poshychinda M, Ekins RP. Pregnancy-induced changes in thyroid function:role of human chorionic gonadotropin as putativeregulator of maternal thyroid. J Clin EndocrinolMetab 1991;73:824-831. https://doi.org/10.1210/jcem-73-4-824.

  13. Grün JP, Meuris S, De Nayer P, Glinoer D.The thyrotrophic role of human chorionic gonadotrophin(hCG) in the early stages of twin(versus single) pregnancies. Clin Endocrinol(Oxf) 1997;46:719-725. https://doi.org/10.1046/j.1365-2265.1997.2011011.x.

  14. Maia AL, Goemann IM, Meyer EL, Wajner SM.Deiodinases: the balance of thyroid hormone:type 1 iodothyronine deiodinase in human physiologyand disease. J Endocrinol 2011;209:283-297. https://doi.org/10.1530/joe-10-0481.

  15. Kester MH, Kaptein E, Van Dijk CH, RoestTJ, Tibboel D, Coughtrie MW, et al. Characterizationof iodothyronine sulfatase activitiesin human and rat liver and placenta. Endocrinology2002;143:814-819. https://doi.org/10.1210/endo.143.3.8686.

  16. Silva JF, Ocarino NM, Serakides R. Thyroid hormonesand female reproduction. Biol Reprod2018;99:907-921. https://doi.org/10.1093/biolre/ioy115.

  17. Dentice M, Marsili A, Zavacki A, Larsen PR,Salvatore D. The deiodinases and the controlof intracellular thyroid hormone signalingduring cellular differentiation. Biochim BiophysActa 2013;1830:3937-3945. https://doi.org/10.1016/j.bbagen.2012.05.007.

  18. Ferreiro B, Bernal J, Goodyer CG, BranchardCL. Estimation of nuclear thyroid hormone receptorsaturation in human fetal brain and lungduring early gestation. J Clin Endocrinol Metab

  19. 1988;67:853-856. https://doi.org/10.1210/jcem-67-4-853.19. López-Muñoz E, Mateos-Sánchez L, Mejía-Terrazas GE, Bedwell-Cordero SE. Hypothyroidismand isolated hypothyroxinemia in pregnancy,from physiology to the clinic. Taiwan JObstet Gynecol 2019;58:757-763. https://doi.org/10.1016/j.tjog.2019.09.005.

  20. Loubière LS, Vasilopoulou E, Bulmer JN, TaylorPM, Stieger B, Verrey F, et al. Expression ofthyroid hormone transporters in the human placentaand changes associated with intrauterinegrowth restriction. Placenta 2010;31:295-304.https://doi.org/10.1016/j.placenta.2010.01.013.

  21. Fantz CR, Dagogo-Jack S, Ladenson JH, GronowskiAM. Thyroid function during pregnancy.Clin Chem 1999;45:2250-2258.

  22. Zhang X, Li C, Mao J, Wang W, Xie X, PengS, et al. Gestation-specific changes in maternalthyroglobulin during pregnancy and lactation inan iodine-sufficient region in China: a longitudinal study. Clin Endocrinol (Oxf) 2017;86:229-

  23. https://doi.org/10.1111/cen.13175.23. Sirakov M, Skah S, Nadjar J, Plateroti M. Thyroidhormone's action on progenitor/stem cell biology:new challenge for a classic hormone?Biochim Biophys Acta 2013;1830:3917-3927.https://doi.org/10.1016/j.bbagen.2012.07.014.

  24. Burrow GN, Fisher DA, Larsen PR. Maternaland fetal thyroid function. N Engl J Med1994;331:1072-1078. https://doi.org/10.1056/nejm199410203311608.

  25. Institute of Medicine. Dietary reference intakes:Applications in dietary assessment. Washington,DC: The National Academies Press; 2000. ISBN:978-0-309-07183-3.

  26. Wang Z, Li C, Teng Y, Guan Y, Zhang L, Jia X,et al. The effect of iodine-containing vitaminsupplementation during pregnancy on thyroidfunction in late pregnancy and postpartum depressionin an iodine-sufficient area. Biol TraceElem Res 2020;198:1-7. https://doi.org/10.1007/s12011-020-02032-y.

  27. World Health Organization (WHO), InternationalCouncil for the Control of the Iodine DeficiencyDisorders, United Nations Children’sFund. Assessment of iodine deficiency disordersand monitoring their elimination: a guide forprogramme managers. 3rd ed. Geneva: WorldHealth Organization; 2007.

  28. Völzke H, Erlund I, Hubalewska-DydejczykA, Ittermann T, Peeters RP, Rayman M, et al.How do we improve the impact of iodine deficiencydisorders prevention in europe and beyond?Eur Thyroid J 2018;7:193-200. https://doi.org/10.1159/000490347.

  29. Vargas-Uricoechea H, Murillo-Palacios J, Ramírez-Bejarano LE. Análisis del estado poblacionaldel yodo en Colombia y la necesidad demodificar los niveles de yodación universal dela sal. Revista Colomb Endocrinología DiabetesMetab 2020;7:87-98. https://doi.org/10.53853/encr.7.2.608.

  30. Kwak-Kim J, Bao S, Lee SK, Kim JW, Gilman-Sachs A. Immunological modes of pregnancyloss: inflammation, immune effectors, and stress.Am J Reprod Immunol 2014;72:129-140. https://doi.org/10.1111/aji.12234.

  31. Morelli S MM, Goldsmith LT, Kashani BN, PonzioNM. The maternal immune system duringpregnancy and its influence on fetal development.Res Rep Biol 2015;6:171-189. https://doi.org/https://doi.org/10.2147/RRB.S80652.

  32. Kim NY, Cho HJ, Kim HY, Yang KM, Ahn HK,Thornton S, et al. Thyroid autoimmunity andits association with cellular and humoral immunityin women with reproductive failures. Am JReprod Immunol 2011;65:78-87. https://doi.org/10.1111/j.1600-0897.2010.00911.x.

  33. Weetman AP. Diseases associated withthyroid autoimmunity: explanations for theexpanding spectrum. Clin Endocrinol (Oxf)2011;74:411-418. https://doi.org/10.1111/j.1365-2265.2010.03855.x.

  34. Shields BM, Knight BA, Hill AV, HattersleyAT, Vaidya B. Five-year follow-up for womenwith subclinical hypothyroidism in pregnancy.J Clin Endocrinol Metab 2013;98:E1941-1945.https://doi.org/10.1210/jc.2013-2768.

  35. Nambiar V, Jagtap VS, Sarathi V, Lila AR, KamalanathanS, Bandgar TR, et al. Prevalenceand impact of thyroid disorders on maternaloutcome in Asian-Indian pregnant women. JThyroid Res 2011;2011:429097. https://doi.org/10.4061/2011/429097.

  36. De Leo S, Pearce EN. Autoimmune thyroid diseaseduring pregnancy. Lancet Diabetes Endocrinol2018;6:575-586. https://doi.org/10.1016/s2213-8587(17)30402-3.

  37. Negro R, Formoso G, Mangieri T, PezzarossaA, Dazzi D, Hassan H. Levothyroxinetreatment in euthyroid pregnant women withautoimmune thyroid disease: effects on obstetricalcomplications. J Clin Endocrinol Metab2006;91:2587-2591. https://doi.org/10.1210/jc.2005-1603.

  38. Mammen JS, Cappola AR. Autoimmune thyroiddisease in women. JAMA 2021;325:2392-2393.https://doi.org/10.1001/jama.2020.22196.

  39. Bagis T, Gokcel A, Saygili ES. Autoimmunethyroid disease in pregnancy and the postpartumperiod: relationship to spontaneous abortion.Thyroid 2001;11:1049-1053. https://doi.org/10.1089/105072501753271743.

  40. Pradhan M, Anand B, Singh N, Mehrotra M.Thyroid peroxidase antibody in hypothyroidism:it's effect on pregnancy. J Matern FetalNeonatal Med 2013;26:581-583. https://doi.org/10.3109/14767058.2012.745498.

  41. Toulis KA, Goulis DG, Venetis CA, KolibianakisEM, Negro R, Tarlatzis BC, et al. Risk ofspontaneous miscarriage in euthyroid womenwith thyroid autoimmunity undergoing IVF: ameta-analysis. Eur J Endocrinol 2010;162:643-652. https://doi.org/10.1530/eje-09-0850.

  42. Thangaratinam S, Tan A, Knox E, Kilby MD,Franklyn J, Coomarasamy A. Association betweenthyroid autoantibodies and miscarriageand preterm birth: meta-analysis of evidence.Bmj 2011;342:d2616. https://doi.org/10.1136/bmj.d2616.

  43. He X, Wang P, Wang Z, He X, Xu D, Wang B.Thyroid antibodies and risk of preterm delivery:a meta-analysis of prospective cohort studies.Eur J Endocrinol 2012;167:455-464. https://doi.org/10.1530/eje-12-0379.

  44. Negro R. Thyroid autoimmunity and pre-termdelivery: brief review and meta-analysis. J EndocrinolInvest 2011;34:155-158. https://doi.org/10.1007/bf03347047.

  45. Kumru P, Erdogdu E, Arisoy R, Demirci O,Ozkoral A, Ardic C, et al. Effect of thyroid dysfunctionand autoimmunity on pregnancy outcomesin low risk population. Arch Gynecol Obstet2015;291:1047-1054. https://doi.org/10.1007/s00404-014-3533-9.

  46. Wasserman EE, Nelson K, Rose NR, Eaton W,Pillion JP, Seaberg E, et al. Maternal thyroidautoantibodies during the third trimester andhearing deficits in children: an epidemiologicassessment. Am J Epidemiol 2008;167:701-710.https://doi.org/10.1093/aje/kwm342.

  47. Williams FLR, Watson J, Ogston SA, Visser TJ,Hume R, Willatts P. Maternal and umbilical cordlevels of T4, FT4, TSH, TPOAb, and TgAb in terminfants and neurodevelopmental outcome at 5.5years. J Clin Endocrinol Metab 2013;98:829-838. https://doi.org/10.1210/jc.2012-3572.

  48. Ghassabian A, Bongers-Schokking JJ, deRijke YB, van Mil N, Jaddoe VW, de MuinckKeizer-Schrama SM, et al. Maternal thyroidautoimmunity during pregnancy and the riskof attention deficit/hyperactivity problemsin children: the Generation R Study. Thyroid2012;22:178-186. https://doi.org/10.1089/thy.2011.0318.

  49. Bestwick JP, John R, Maina A, Guaraldo V,Joomun M, Wald NJ, et al. Thyroid stimulatinghormone and free thyroxine in pregnancy: expressingconcentrations as multiples of the median(MoMs). Clin Chim Acta 2014;430:33-37.https://doi.org/10.1016/j.cca.2013.12.030.

  50. La'ulu SL, Roberts WL. Ethnic differencesin first-trimester thyroid reference intervals.Clin Chem 2011;57:913-915. https://doi.org/10.1373/clinchem.2010.161240.

  51. Männistö T, Surcel HM, Ruokonen A, VääräsmäkiM, Pouta A, Bloigu A, et al. Early pregnancyreference intervals of thyroid hormoneconcentrations in a thyroid antibody-negativepregnant population. Thyroid 2011;21:291-298. https://doi.org/10.1089/thy.2010.0337.

  52. Lee RH, Spencer CA, Mestman JH, Miller EA,Petrovic I, Braverman LE, et al. Free T4 immunoassaysare flawed during pregnancy. Am JObstet Gynecol 2009;200:260-266. https://doi.org/10.1016/j.ajog.2008.10.042.

  53. Soldin OP, Tractenberg RE, Hollowell JG,Jonklaas J, Janicic N, Soldin SJ. Trimesterspecificchanges in maternal thyroid hormone,thyrotropin, and thyroglobulin concentrationsduring gestation: trends and associationsacross trimesters in iodine sufficiency. Thyroid2004;14:1084-1090. https://doi.org/10.1089/thy.2004.14.1084.

  54. Yue B, Rockwood AL, Sandrock T, La'ulu SL,Kushnir MM, Meikle AW. Free thyroid hormonesin serum by direct equilibrium dialysisand online solid-phase extraction--liquidchromatography/tandem mass spectrometry.Clin Chem 2008;54:642-651. https://doi.org/10.1373/clinchem.2007.098293.

  55. Allan WC, Haddow JE, Palomaki GE, WilliamsJR, Mitchell ML, Hermos RJ, et al.Maternal thyroid deficiency and pregnancycomplications: implications for populationscreening. J Med Screen 2000;7:127-130.https://doi.org/10.1136/jms.7.3.127.

  56. Blatt AJ, Nakamoto JM, Kaufman HW. Nationalstatus of testing for hypothyroidismduring pregnancy and postpartum. J Clin EndocrinolMetab 2012;97:777-784. https://doi.org/10.1210/jc.2011-2038.

  57. Smith TJ, Bahn RS, Gorman CA. Connectivetissue, glycosaminoglycans, and diseases of thethyroid. Endocr Rev 1989;10:366-391. https://doi.org/10.1210/edrv-10-3-366.

  58. Leung AS, Millar LK, Koonings PP, Montoro M,Mestman JH. Perinatal outcome in hypothyroidpregnancies. Obstet Gynecol 1993;81:349-353.

  59. Männistö T, Mendola P, Grewal J, Xie Y, ChenZ, Laughon SK. Thyroid diseases and adversepregnancy outcomes in a contemporary UScohort. J Clin Endocrinol Metab 2013;98:2725-2733. https://doi.org/10.1210/jc.2012-4233.

  60. Idris I, Srinivasan R, Simm A, Page RC. Maternalhypothyroidism in early and late gestation:effects on neonatal and obstetric outcome. ClinEndocrinol (Oxf) 2005;63:560-565. https://doi.org/10.1111/j.1365-2265.2005.02382.x.

  61. Willoughby KA, McAndrews MP, Rovet JF.Effects of maternal hypothyroidism on offspringhippocampus and memory. Thyroid2014;24:576-584. https://doi.org/10.1089/thy.2013.0215.

  62. Liu H, Shan Z, Li C, Mao J, Xie X, Wang W, et al.Maternal subclinical hypothyroidism, thyroid autoimmunity,and the risk of miscarriage: a prospectivecohort study. Thyroid 2014;24:1642-1649. https://doi.org/10.1089/thy.2014.0029.

  63. Korevaar TI, Schalekamp-Timmermans S, deRijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, et al. Hypothyroxinemia andTPO-antibody positivity are risk factors for prematuredelivery: the generation R study. J ClinEndocrinol Metab 2013;98:4382-4390. https://doi.org/10.1210/jc.2013-2855.

  64. Korevaar TIM, Derakhshan A, Taylor PN, MeimaM, Chen L, Bliddal S, et al. Association ofthyroid function test abnormalities and thyroidautoimmunity with preterm birth: A systematicreview and meta-analysis. JAMA 2019;322:632-641. https://doi.org/10.1001/jama.2019.10931.

  65. Maraka S, Singh-Ospina NM, O'Keeffe DT,Rodriguez-Gutierrez R, Espinosa-De YcazaAE, Wi CI, et al. Effects of increasing levothyroxineon pregnancy outcomes in womenwith uncontrolled hypothyroidism. ClinEndocrinol (Oxf) 2017;86:150-155. https://doi.org/10.1111/cen.13168.

  66. Rotondi M, Capelli V, Chiovato L, Nappi RE.2017 ATA guidelines on the management ofthyroid dysfunctions in pregnancy: what doOB/GYNs need to know? Gynecol Endocrinol2019;35:276-279. https://doi.org/10.1080/09513590.2018.1532496.

  67. Nelson SM, Haig C, McConnachie A, SattarN, Ring SM, Smith GD, et al. Maternal thyroidfunction and child educational attainment:prospective cohort study. BMJ 2018;360:k452.https://doi.org/10.1136/bmj.k452.

  68. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, PorterTF, et al. Maternal thyroid hypofunctionand pregnancy outcome. Obstet Gynecol2008;112:85-92. https://doi.org/10.1097/AOG.0b013e3181788dd7.

  69. Taylor PN, Minassian C, Rehman A, Iqbal A,Draman MS, Hamilton W, et al. TSH levels andrisk of miscarriage in women on long-term levothyroxine:a community-based study. J ClinEndocrinol Metab 2014;99:3895-3902. https://doi.org/10.1210/jc.2014-1954.

  70. Nazarpour S, Ramezani Tehrani F, AmiriM, Bidhendi Yarandi R, Azizi F. Levothyroxinetreatment and pregnancy outcomes inwomen with subclinical hypothyroidism: asystematic review and meta-analysis. Arch GynecolObstet 2019;300:805-819. https://doi.org/10.1007/s00404-019-05245-2.

  71. Bein M, Yu OHY, Grandi SM, Frati FYE, KandilI, Filion KB. Levothyroxine and the risk ofadverse pregnancy outcomes in women withsubclinical hypothyroidism: a systematic reviewand meta-analysis. BMC Endocr Disord2021;21:34. https://doi.org/10.1186/s12902-021-00699-5.

  72. Negro R, Schwartz A, Gismondi R, TinelliA, Mangieri T, Stagnaro-Green A. Increasedpregnancy loss rate in thyroid antibody negativewomen with TSH levels between 2.5 and5.0 in the first trimester of pregnancy. J ClinEndocrinol Metab 2010;95:e44-48. https://doi.org/10.1210/jc.2010-0340.

  73. Zhou Q, Wang C, Xu H, Li X. Impact of preconceptiontreatment initiation for hypothyroidismon neurocognitive function in children. JClin Endocrinol Metab 2020;105: e3919-3928.https://doi.org/10.1210/clinem/dgaa565.

  74. Dhillon-Smith RK, Middleton LJ, Sunner KK,Cheed V, Baker K, Farrell-Carver S, et al. Levothyroxinein women with thyroid peroxidaseantibodies before conception. N Engl J Med2019;380:1316-1325. https://doi.org/10.1056/NEJMoa1812537.

  75. Casey BM, Thom EA, Peaceman AM,Varner MW, Sorokin Y, Hirtz DG, et al.Treatment of subclinical hypothyroidism orhypothyroxinemia in pregnancy. N Engl J Med2017;376:815-825. https://doi.org/10.1056/NEJMoa1606205.

  76. Bath SC, Rayman MP. Antenatal thyroid screeningand childhood cognitive function. NEngl J Med 2012;366:1640-1641. https://doi.org/10.1056/NEJMc1202720.

  77. Negro R, Schwartz A, Gismondi R, TinelliA, Mangieri T, Stagnaro-Green A. Universalscreening versus case finding for detectionand treatment of thyroid hormonal dysfunctionduring pregnancy. J Clin Endocrinol Metab2010;95:1699-1707. https://doi.org/10.1210/jc.2009-2009.

  78. Jouyandeh Z, Hasani-Ranjbar S, Qorbani M,Larijani B. Universal screening versus selectivecase-based screening for thyroid disordersin pregnancy. Endocrine 2015;48:116-123.https://doi.org/10.1007/s12020-014-0385-9.

  79. Gómez-Sanchez P, Arévalo-Rodríguez I, Collazos-Vidal C. Guías de práctica clínica para laprevención, detección temprana y tratamientode las complicaciones del embarazo, parto opuerperio. Centro Nacional de Investigaciónen Evidencia y Tecnologías en Salud (CINETS),Ministerio de Salud y Protección Social. GuíasNo. 11-15. Bogotá D.C.: Ministerio de Salud yProtección Social-Colciencias; 2013. Acceso 15de agosto de 2021. Disponible en https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/Gu%C3%ADa.completa.Embarazo.Parto.2013.pdf.

  80. Rotondi M, Chiovato L, Pacini F, BartalenaL, Vitti P. Management of subclinical hypothyroidismin pregnancy: A comment fromthe Italian Society of Endocrinology and theItalian Thyroid Association to the 2017 AmericanThyroid Association guidelines-"the Italianway". Thyroid 2018;28:551-555. https://doi.org/10.1089/thy.2017.0424.

  81. Rago T, Chiovato L, Grasso L, Pinchera A, VittiP. Thyroid ultrasonography as a tool for detectingthyroid autoimmune diseases and predictingthyroid dsfunction in apparently healthysubjects. J Endocrinol Invest 2001;24:763-769.https://doi.org/10.1007/bf03343925.

  82. Biondi B, Bartalena L, Cooper DS, HegedüsL, Laurberg P, Kahaly GJ. The 2015 EuropeanThyroid Association Guidelines on diagnosisand treatment of endogenous subclinical hyperthyroidism.Eur Thyroid J 2015;4:149-163.https://doi.org/10.1159/000438750.

  83. Alexander EK, Marqusee E, Lawrence J, JarolimP, Fischer GA, Larsen PR. Timing andmagnitude of increases in levothyroxine requirementsduring pregnancy in women withhypothyroidism. N Engl J Med 2004;351:241-249. https://doi.org/10.1056/NEJMoa040079.




2020     |     www.medigraphic.com